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Identity 
Other names: TBX3-ISO, UMS, XHL 
HGNC (Hugo): TBX3 
Location: 12q24.1 
Note 
TBX3 is a member of the T-box transcription factor 
family, characterised by a conserved DNA-binding 
domain known as the T-box (Kispert and Herrmann, 
1993; Bollag et al., 1994; Agulnik et al., 1996; 
reviewed in Papaioannou, 2001). TBX3 belongs to the 
Tbx2 (also known as the Tbx2/3/4/5) subfamily, which 
includes the closely related genes Tbx2, Tbx3, Tbx4 
and Tbx5 (Showell et al., 2004; Naiche et al., 2005).  
Tbx3 plays critical roles in the development of several 
organs such as the heart, limb and mammary gland 
(Davenport et al., 2003; Hoogaars et al., 2007).  
TBX3 is overexpressed in a range of cancers including 
breast, pancreatic and melanoma and has been directly 
implicated in tumourigenesis (Mahlamaki et al., 200; 
Fan et al., 2004; Hoek et al., 2004).  
It has been reported to promote evasion of apoptosis, 
migration, invasion and tumour forming ability 
(Brummelkamp et al., 2002; Ito et al., 2005; Renard et 
al., 2007; Peres et al., 2010). 
DNA/RNA 
Note 
Tbx2 and Tbx3 both belong to the Tbx2 subfamily of 
T-box factors (Agulnik et al., 1996). Phylogenetic 
analysis suggests that this subfamily originated from a 
single ancestral gene which was  
duplicated by unequal crossing over to form a two-gene 
cluster (Tbx2/3 and Tbx4/5) and at some point in the 
vertebrate lineage, duplicated again to form four 
separate genes with Tbx2 and Tbx4 linked on 
chromosome 11, and Tbx3 and Tbx5 on chromosome 5 
(chromosomes 17q23 and 12q24 respectively in 
humans; Figure 1A) (Campbell et al., 1995; Agulnik et 
al., 1996; Bamshad et al., 1997).  
Due to the original duplication event, Tbx2 and Tbx3 
form a closely related gene pair while Tbx4 and Tbx5 
are more closely related to each other (Agulnik et al., 
1996). 
Description 
The human TBX3 gene is found on the reverse strand 
of chromosome 12 and spans 13.9 kb. 
Transcription 
Four TBX3 transcripts have been identified but only 
two encode for full length functional proteins viz TBX3 
and TBX3 + 2a (Figure 1B). The TBX3 mRNA is 4.7 
kb and contains 7 exons encoding a protein of 723 
amino acids.  
Alternative splicing of the intronic region between 
exons 2 and 3 gives rise to the TBX3 + 2a transcript 
which contains an extra 60 bp sequence designated 
exon 2a leading to the production of a 743 amino acid
protein (Bamshad et al., 1999). TBX3 and TBX3 + 2a 
isoforms are widely expressed in mouse and human 
tissues with TBX3 generally observed to be the 
dominant isoform and the ratio between the two being 
both tissue and species dependent (Fan et al., 2004). 
Pseudogene 
No pseudogenes have been identified for TBX3 to date. 
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Figure 1: A) Drawing of gene duplication. B) Drawing of TBX3 mRNA. (A) Model describing evolution of Tbx 2/3/4/5 gene family 
(based on Agulnick et al., 1996). (B) Schematic representation of human TBX3 mRNA depicting relative size and position of exons. In the 




The TBX3 + 2a transcript yields a protein with an extra 
20 amino acids in the middle of the T-box DNA 
binding domain, giving rise to speculation that it may 
affect the DNA-binding ability of the protein (Bamshad 
et al., 1999).  
While the work of Fan et al. (2004) has provided 
evidence supporting this hypothesis, subsequent studie  
have shown no functional difference between the 
TBX3 and TBX3 + 2a proteins (Hoogaars et al., 2008; 
Rodriguez et al., 2008). 
Description 
The T-box DNA binding domain is found in the N-
terminal half of the TBX3 protein extending from 
amino acids 104 - 285 and in the TBX3 + 2a isoform, 
the additional 20 amino acids are inserted into the 
middle of the T-box at position 219 (Figure 2). TBX3 
has two repression domains, one in the N-terminus ad  
one in the C-terminus of the protein, as well as a 
putative activation domain located in the C-terminal 
end of the protein (Figure 2) (Carlson et al., 2001). 
Expression 
In humans, TBX3 is expressed in a number of organs, 
including foetal heart, liver, spleen, lung and kidney, 
and in adult prostate, lung, placenta, ovary, spleen, 
heart, kidney, testis, small intestine, adrenal gland, 
thyroid, breast, bladder, uterus, liver and salivary gland 
(Bamshad et al., 1999). 
Localisation 
The TBX3 protein is predominantly nuclear. 
Function 
TBX3 has been described to function as a 
transcriptional repressor and to date was shown to 
directly repress p14, p21, E-cadherin and phosphatase 
and TENsin homolog (PTEN) (Lingbeek et al., 2002; 
Hoogaars et al., 2008; Rodriguez et al., 2008; Burgucu 
et al., 2012).  
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Figure 2. Schematic representation of the human TBX3 protein. The domains depicted above are: T-box, DNA binding domain (pink); 
R, repression domain; A, putative activation domain. The amino and carboxy termini of the protein are labelled N and C respectively. 
 
While in vitro assays have suggested that TBX3 is 
capable of transcriptional activation, it has not ye been 
shown to activate any physiologically relevant target 
genes. 
Homology 
Human TBX3 shares 98% amino acid identity with 
mouse Tbx3 and homologs have been identified in 
mammals, reptiles, fish and amphibians, as well as 
invertebrates such as tunicates (Bamshad et al., 1997). 
Mutations 
Germinal 
Mutations in human TBX3 have been linked with 
ulnar-mammary syndrome and those described to date 
include frame shift, premature termination and 





Results from congenital mutations in a single copy f 
the human TBX3 gene. 
Disease 
Characterised by posterior limb abnormalities, such as 
malformed ulna and posterior digits, hypoplasia and/or 
dysfunction of the mammary and apocrine glands, 
absent axillary hair, abnormal dentition, delayed 
puberty in males and genital anomalies (Bamshad et l., 
1996; Bamshad et al., 1997). 
Breast cancer 
Note 
Breast cancer lines screened by real time PCR analysis 
displayed increased expression of TBX3 in 15 of 28 
cell lines tested (Fan et al., 2004).  
When TBX3 expression was examined by 
immunohistochemistry in breast tumour tissues, the 
results showed that levels of TBX3 protein were higher 
in tumour tissue compared to adjacent normal tissue, 
with increased cytoplasmic localisation. 
Pancreatic cancer 
Note 
Microarray analyses comparing non-metastatic and 
metastatic pancreatic endocrine neoplasms revealed 
that TBX3 expression is upregulated in the latter 
tumour type (Hansel et al., 2004). 
Ovarian cancer 
Note 
Using 2D gel electrophoresis and matrix-assisted laser 
desorption/ionization (MALDI) time of flight (TOF) 
mass spectrometry, a truncated form of TBX3 was 
detected in blood plasma from ovarian cancer patients 
(Lomnytska et al., 2006). 
Liver cancer 
Note 
Increased TBX3 expression was shown to correlate 
with a mutant active form of β-catenin in both human 
and mouse hepatocellular carcinomas (HCCs) and 
human hepatoblastomas.  
Renard et al. (2007) demonstrated TBX3 to be involved 
in β-catenin's activation of cell proliferation in the 
human hepatoma cell line HepG2.  
Using in vitro assays they showed that expression of 
mutant β-catenin upregulated TBX3 expression and 
that this was due to direct binding of active β-catenin 
together with its co-activator T-cell factor (Tcf) to a 




Genome-wide DNA methylation profiling of 55 
glioblastoma tissue samples compared to non-
neoplastic brains revealed that methylation of TBX3 
correlated with decreased overall survival, identifying 
it as a potential independent prognostic marker 
(Etcheverry et al., 2010). 
Gastric cancer 
Note 
Genome-wide screening identified TBX3 to be 
epigenetically silenced in the gastric cancer cell line 
AGS and the TBX3 gene was shown to be methylated 
in 7 out of 10 primary gastric cancers (Yamashita et l., 
2006). 
Uterine cervical cancer 
Note 
TBX3 expression was shown to be downregulated in 
microarray analyses comparing lymph node positive to 
lymph node negative cervical tumours. A significant 
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correlation was observed between low TBX3 
expression and the metastatic phenotype. In addition, 
multivariate analysis identified TBX3 as a potential 




In 2004, Hoek et al. showed that compared to normal 
melanocytes TBX3 expression was upregulated in at 
least 4 of 6 melanoma cell lines tested and Rodriguez et 
al. (2008) later demonstrated increased TBX3 protein 
levels in 6 out of 12 melanoma cell lines. Furthermore, 
TBX3 was shown to contribute to melanoma formation, 
migration and invasion by a process involving its 
ability to repress the cell adhesion molecule E-cadherin 
(Rodriguez et al., 2008; Peres et al., 2010). 
Head and neck squamous cell cancer 
Note 
TBX3 is upregulated in head and neck squamous cell 
carcinoma (HNSCC) cell lines and tissues (Humtsoe et 
al., 2011; Burgucu et al., 2012). The study by Humtsoe 
et al. shows that TBX3 expression is specifically 
upregulated in HNSCC cells which display 
characteristics of epithelial to mesenchymal transition 
(EMT). Interestingly, however they show that TBX3 
promotes cell survival and to a lesser extent, cell 
invasion in these cells (Humtsoe et al., 2011). This is 
consistent with the results of Burgucu et al. (2012) 
which demonstrate that TBX3 represses the tumour 
suppressor, phosphatase and TENsin homolog (PTEN). 
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